THE VISION OF A PIONEER CRO:
As a CRO pioneer in the digital world,
We strongly believe in our people & digital-centric vision, in which interconnections between people’s health & digitization become evident and link smoothly with one another.
We nimbly observe and interact with people, listen to their needs, helping Research and Researchers to streamline the clinical trial process and to generate smart evidence for the Future of Healthcare.
EVIDENCE
BASED CARE
HEALTH TRENDS
AND
ECONOMICS
HEALTHCARE
PROFESSIONAL
ATTITUDES
Real world platform
At Evidilya we are driving health innnovation, integrated with a decentralized setting through an active analysis of physical, digital and biological assets together with a variety of e-solutions, designed for real-time information capture. This new, flexible, evidence-based approach is able to exactly understand and highlight people’s demands and attitudes, driving innovative evidence.
CUSTOMIZED CLINICAL & PRE-CLINICAL TRIALS
WORLD-WIDE EXCELLENCE RESEARCH CENTERS
E-CONNECTED HEALTHCARE EXPERTISE
Clinical platform
At Evidilya we realize and valorize evidence-based outcomes from a wide range of international clinical trials. This is possible thanks to our scientific expertise, a seamless global network of partnerships and worldwide research centers of excellence in DCTs studies.
CUSTOMIZED CLINICAL
& PRE-CLINICAL
TRIALS
WORLD-WIDE
EXCELLENCE
RESEARCH CENTERS
E-CONNECTED
HEALTHCARE
EXPERTISE
Follow us on
Evidilya People-Centric Approach: our biggest resource!
The People-Centric Approach is the pillar through which Evidilya is continuously accelerating Health innovation: we drive studies according to our PHYGITAL-CROWD enrolment strategies, Participants and Study Stakeholders Virtual management Platforms and Direct to Participant Concierge Support Programme.
V-PROTECT: the RWE 100% virtual study about Covid-19 vaccination
Finally, in Europe a 100% virtual research and People-Generated Data that will allow us to study the relationship between vaccination against Covid-19 and health at 360°, as regards nutrition and lifestyles.
Evidilya has been awarded with the Crédit d’Impôt Recherche (CIR)
Evidilya, the Evidence Generation CRO acting worldwide in the Pharmaceutical and CHC field, has been awarded with the Crédit d'Impôt Recherche (CIR) from the French ministère de l'Enseignement supérieur
FDA’s direction on vaccine development against COVID-19
The U.S Food and Drug Administration has released its standards on how it will proceed to analyze experimental vaccines against the SARS-CoV-2.
Covid-19 Clinical Research Coalition
With the aim of accelerating COVID-19 clinical research in resource-limited settings, a Global Coalition was established, based on multinational and multidisciplinary expertise and clinical trial capacity.
The Pistoia Alliance: how to lower barriers to innovation in life sciences R&D
The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences R&D, has recently released the latest Unified Data Model (UDM) file format, Version 6. The aim of the UDM project is to create and publish an open and freely available data format for the storage and exchange of experimental information regarding compound synthesis and testing.
Clinical trials management in Italy during the COVID-19 emergency
The Italian Medicines Agency (AIFA) has recently provided some guidelines regarding the management of clinical trials in Italy that will be valid until further notice.
Evidilya’s contribution for the RhinAsthma Patient’s Perspective (RAPP)
We are pleased to announce that Evidilya has participated as CRO in a multinational study aimed at evaluating the psychometric properties of the RAPP.
Real World Evidence for Rare Diseases
Rare disease day was celebrated on the rarest day in the year: February 29th, 2020. There are 7000 known rare diseases, defined as diseases that affect fewer than 200,000 people in the USA. For rare diseases, the challenge is that it is often not feasible to conduct traditional randomized phase III clinical trials.
First clinical trial to evaluate the safety and efficacy of an antiviral in adults with COVID-19
The University of Nebraska Medical Center (UNMC) has started a randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with COVID-19.
The importance of RWD and RWE for FDA
This is the main topic addressed by FDA Commissioner Stephen Hahn during an all-hands first meeting with FDA staffers.
How we operate
Thanks to the international, multidisciplinary network of experts and the co-existence of the Real-World and Clinical Platform, Evidilya offers tangible solutions and reliable results in the field of disease prevention and supporting therapies.
Human data science
to characterize and validate self-perception of health status by identifying measurable outcomes
Real expertise
observing, listening to and mapping people’s experience to understand the dynamics of their behavior in Real Life
Exponential technology
to guarantee the quality and significance of data also in a real-life environment and a significant volume of inputs directly from Real-Life Patient Experiences
Patient care experience
for an in-depth exploration of the underlying motivations behind habits and attitudes in Real Life, through an immersive, insightful, people-centered approach
How we operate
Thanks to the international, multidisciplinary network of experts and the co-existence of the Real-World and Clinical Platform, Evidilya offers tangible solutions and reliable results in the field of disease prevention and supporting therapies.
Human data science
to characterize and validate self-perception of health status by identifying measurable outcomes
Real expertise
observing, listening to and mapping people’s experience to understand the dynamics of their behavior in Real Life
Exponential technology
to guarantee the quality and significance of data also in a real-life environment and a significant volume of inputs directly from Real-Life Patient Experiences
Patient care experience
for an in-depth exploration of the underlying motivations behind habits and attitudes in Real Life, through an immersive, insightful, people-centered approach
Evidilya People-Centric Approach: our biggest resource!
The People-Centric Approach is the pillar through which Evidilya is continuously accelerating Health innovation: we drive studies according to our PHYGITAL-CROWD enrolment strategies, Participants and Study Stakeholders Virtual management Platforms and Direct to Participant Concierge Support Programme.